McKesson Common Stock Net 2010-2025 | MCK

McKesson common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
  • McKesson common stock net for the quarter ending March 31, 2025 was $3M, a 0% increase year-over-year.
  • McKesson common stock net for 2025 was $0.003B, a 0% decline from 2024.
  • McKesson common stock net for 2024 was $0.003B, a 0% decline from 2023.
  • McKesson common stock net for 2023 was $0.003B, a 50% increase from 2022.
McKesson Annual Common Stock Net
(Millions of US $)
2025 $3
2024 $3
2023 $3
2022 $2
2021 $2
2020 $2
2019 $3
2018 $3
2017 $3
2016 $3
2015 $4
2014 $4
2013 $4
2012 $4
2011 $4
2010 $4
2009 $4
McKesson Quarterly Common Stock Net
(Millions of US $)
2025-03-31 $3
2024-12-31 $3
2024-09-30 $3
2024-06-30 $3
2024-03-31 $3
2023-12-31 $3
2023-09-30 $3
2023-06-30 $3
2023-03-31 $3
2022-12-31 $3
2022-09-30 $3
2022-06-30 $3
2022-03-31 $2
2021-12-31 $2
2021-09-30 $2
2021-06-30 $2
2021-03-31 $2
2020-12-31 $2
2020-09-30 $2
2020-06-30 $2
2020-03-31 $2
2019-12-31 $3
2019-09-30 $3
2019-06-30 $3
2019-03-31 $3
2018-12-31 $3
2018-09-30 $3
2018-06-30 $3
2018-03-31 $3
2017-12-31 $3
2017-09-30 $3
2017-06-30 $3
2017-03-31 $3
2016-12-31 $3
2016-09-30 $3
2016-06-30 $3
2016-03-31 $3
2015-12-31 $3
2015-09-30 $4
2015-06-30 $4
2015-03-31 $4
2014-12-31 $4
2014-09-30 $4
2014-06-30 $4
2014-03-31 $4
2013-12-31 $4
2013-09-30 $4
2013-06-30 $4
2013-03-31 $4
2012-12-31 $4
2012-09-30 $4
2012-06-30 $4
2012-03-31 $4
2011-12-31 $4
2011-09-30 $4
2011-06-30 $4
2011-03-31 $4
2010-12-31 $4
2010-09-30 $4
2010-06-30 $4
2010-03-31 $4
2009-12-31 $4
2009-09-30 $4
2009-06-30 $4
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $89.591B $359.051B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $49.119B 12.16
Cardinal Health (CAH) United States $36.458B 19.09
Straumann Holding AG (SAUHY) Switzerland $20.442B 0.00
Labcorp (LH) United States $20.300B 16.47
Cooper (COO) United States $15.765B 20.91
West Pharmaceutical Services (WST) United States $14.771B 30.96
Align Technology (ALGN) United States $12.380B 24.58
Henry Schein (HSIC) United States $8.721B 14.96
Merit Medical Systems (MMSI) United States $5.637B 27.25
DENTSPLY SIRONA (XRAY) United States $3.083B 9.21
CONMED (CNMD) United States $1.714B 12.82
STAAR Surgical (STAA) United States $0.925B 0.00
Lifevantage (LFVN) United States $0.159B 16.44
Pro-Dex (PDEX) United States $0.151B 16.51